Annual Operating Profit:
-$535.97M+$33.23M(+5.84%)Summary
- As of today, RARE annual operating income is -$535.97 million, with the most recent change of +$33.23 million (+5.84%) on December 31, 2024.
- During the last 3 years, RARE annual operating profit has fallen by -$154.24 million (-40.40%).
- RARE annual operating profit is now -8069.07% below its all-time high of -$6.56 million, reached on December 31, 2011.
Performance
RARE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$107.89M+$35.05M(+24.52%)Summary
- As of today, RARE quarterly operating income is -$107.89 million, with the most recent change of +$35.05 million (+24.52%) on June 30, 2025.
- Over the past year, RARE quarterly operating profit has increased by +$8.47 million (+7.28%).
- RARE quarterly operating profit is now -2223.67% below its all-time high of -$4.64 million, reached on September 1, 2012.
Performance
RARE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$505.09M+$8.47M(+1.65%)Summary
- As of today, RARE TTM operating income is -$505.09 million, with the most recent change of +$8.47 million (+1.65%) on June 30, 2025.
- Over the past year, RARE TTM operating profit has increased by +$43.76 million (+7.97%).
- RARE TTM operating profit is now -10778.57% below its all-time high of -$4.64 million, reached on September 1, 2012.
Performance
RARE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RARE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +5.8% | +7.3% | +8.0% |
| 3Y3 Years | -40.4% | +23.8% | -7.3% |
| 5Y5 Years | -26.4% | -71.1% | -53.8% |
RARE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -40.4% | +17.4% | at high | +52.1% | at high | +24.9% |
| 5Y | 5-Year | -62.4% | +17.4% | -114.4% | +52.1% | -66.8% | +24.9% |
| All-Time | All-Time | -8069.1% | +17.4% | -2223.7% | +52.1% | >-9999.0% | +24.9% |
RARE Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$107.89M(+24.5%) | -$505.09M(+1.6%) |
| Mar 2025 | - | -$142.94M(-16.9%) | -$513.57M(+4.2%) |
| Dec 2024 | -$535.97M(+5.8%) | -$122.28M(+7.4%) | -$535.97M(-0.0%) |
| Sep 2024 | - | -$131.99M(-13.4%) | -$535.74M(+2.4%) |
| Jun 2024 | - | -$116.36M(+29.6%) | -$548.85M(+5.4%) |
| Mar 2024 | - | -$165.35M(-35.5%) | -$580.45M(-2.0%) |
| Dec 2023 | -$569.21M(+12.3%) | -$122.05M(+15.9%) | -$569.21M(+4.0%) |
| Sep 2023 | - | -$145.10M(+1.9%) | -$592.79M(+11.9%) |
| Jun 2023 | - | -$147.96M(+4.0%) | -$672.76M(-1.0%) |
| Mar 2023 | - | -$154.10M(-5.8%) | -$666.39M(-2.7%) |
| Dec 2022 | -$648.92M(-70.0%) | -$145.63M(+35.3%) | -$648.92M(-7.1%) |
| Sep 2022 | - | -$225.07M(-59.0%) | -$605.86M(-28.7%) |
| Jun 2022 | - | -$141.59M(-3.6%) | -$470.62M(-14.3%) |
| Mar 2022 | - | -$136.63M(-33.2%) | -$411.80M(-7.9%) |
| Dec 2021 | -$381.74M(-15.6%) | -$102.56M(-14.2%) | -$381.74M(-5.4%) |
| Sep 2021 | - | -$89.83M(-8.5%) | -$362.05M(-12.3%) |
| Jun 2021 | - | -$82.78M(+22.3%) | -$322.54M(-6.5%) |
| Mar 2021 | - | -$106.57M(-28.6%) | -$302.82M(+4.4%) |
| Dec 2020 | -$330.12M(+22.2%) | -$82.88M(-64.7%) | -$316.92M(+3.5%) |
| Sep 2020 | - | -$50.31M(+20.2%) | -$328.49M(+17.1%) |
| Jun 2020 | - | -$63.05M(+47.7%) | -$396.20M(+11.1%) |
| Mar 2020 | - | -$120.67M(-27.8%) | -$445.62M(-5.1%) |
| Dec 2019 | -$424.17M(-14.2%) | -$94.45M(+20.0%) | -$424.17M(-1.0%) |
| Sep 2019 | - | -$118.03M(-4.9%) | -$420.06M(-7.2%) |
| Jun 2019 | - | -$112.47M(-13.4%) | -$391.67M(-4.7%) |
| Mar 2019 | - | -$99.21M(-9.8%) | -$374.10M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$371.37M(-12.9%) | -$90.34M(-0.8%) | -$371.37M(+0.1%) |
| Sep 2018 | - | -$89.65M(+5.5%) | -$371.87M(-1.6%) |
| Jun 2018 | - | -$94.90M(+1.6%) | -$365.93M(-4.7%) |
| Mar 2018 | - | -$96.49M(-6.2%) | -$349.48M(-8.2%) |
| Dec 2017 | -$328.94M(-32.6%) | -$90.83M(-8.5%) | -$322.94M(-6.7%) |
| Sep 2017 | - | -$83.71M(-6.7%) | -$302.66M(-6.3%) |
| Jun 2017 | - | -$78.44M(-12.1%) | -$284.73M(-7.7%) |
| Mar 2017 | - | -$69.95M(+0.8%) | -$264.34M(-6.6%) |
| Dec 2016 | -$248.01M(-67.9%) | -$70.55M(-7.2%) | -$248.01M(-6.2%) |
| Sep 2016 | - | -$65.78M(-13.3%) | -$233.62M(-12.4%) |
| Jun 2016 | - | -$58.05M(-8.3%) | -$207.77M(-15.5%) |
| Mar 2016 | - | -$53.62M(+4.5%) | -$179.86M(-21.7%) |
| Dec 2015 | -$147.74M(-160.2%) | -$56.16M(-40.6%) | -$147.74M(-36.1%) |
| Sep 2015 | - | -$39.94M(-32.5%) | -$108.52M(-28.5%) |
| Jun 2015 | - | -$30.14M(-40.2%) | -$84.42M(-24.3%) |
| Mar 2015 | - | -$21.50M(-26.9%) | -$67.94M(-19.7%) |
| Dec 2014 | -$56.78M(-75.9%) | -$16.94M(-7.0%) | -$56.78M(-15.0%) |
| Sep 2014 | - | -$15.84M(-15.9%) | -$49.36M(-19.6%) |
| Jun 2014 | - | -$13.66M(-32.1%) | -$41.29M(-49.5%) |
| Mar 2014 | - | -$10.34M(-8.5%) | -$27.63M(-14.9%) |
| Dec 2013 | -$32.28M(-101.9%) | -$9.53M(-22.7%) | -$24.03M(-25.3%) |
| Sep 2013 | - | -$7.76M(-15.0%) | -$19.19M(-19.4%) |
| Mar 2013 | - | -$6.75M(-44.2%) | -$16.07M(-72.4%) |
| Dec 2012 | -$15.98M(-143.6%) | -$4.68M(-0.8%) | -$9.32M(-100.8%) |
| Sep 2012 | - | -$4.64M | -$4.64M |
| Dec 2011 | -$6.56M | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual operating income?
- What is the all-time high annual operating profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual operating profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly operating profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM operating income?
- What is the all-time high TTM operating profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM operating profit year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual operating income?
The current annual operating profit of RARE is -$535.97M
What is the all-time high annual operating profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual operating income is -$6.56M
What is Ultragenyx Pharmaceutical Inc. annual operating profit year-on-year change?
Over the past year, RARE annual operating income has changed by +$33.23M (+5.84%)
What is Ultragenyx Pharmaceutical Inc. quarterly operating income?
The current quarterly operating profit of RARE is -$107.89M
What is the all-time high quarterly operating profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly operating income is -$4.64M
What is Ultragenyx Pharmaceutical Inc. quarterly operating profit year-on-year change?
Over the past year, RARE quarterly operating income has changed by +$8.47M (+7.28%)
What is Ultragenyx Pharmaceutical Inc. TTM operating income?
The current TTM operating profit of RARE is -$505.09M
What is the all-time high TTM operating profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM operating income is -$4.64M
What is Ultragenyx Pharmaceutical Inc. TTM operating profit year-on-year change?
Over the past year, RARE TTM operating income has changed by +$43.76M (+7.97%)